NEJM Evidence Issues Research Articles in November 2022 Edition
October 26, 2022
October 26, 2022
WALTHAM, Massachusetts, Oct. 26 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its November 2022 edition:
ORIGINAL ARTICLES:
* Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
* Hypothermic versus Normothermic Temperature Control after Cardiac Arrest
* Low-Vol . . .
ORIGINAL ARTICLES:
* Five-Year Analysis of Adjuvant Pembrolizumab or Placebo in Stage III Melanoma
* Hypothermic versus Normothermic Temperature Control after Cardiac Arrest
* Low-Vol . . .